Real-World Evidence of the Cambridge Hybrid Closed-Loop App With a Novel Real-Time Continuous Glucose Monitoring System.

Newman, Christine; Hartnell, Sara; Wilinska, Malgorzata; Alwan, Heba; Hovorka, Roman (2023). Real-World Evidence of the Cambridge Hybrid Closed-Loop App With a Novel Real-Time Continuous Glucose Monitoring System. (In Press). Journal of diabetes science and technology, p. 19322968231187915. Diabetes Technology Society 10.1177/19322968231187915

Full text not available from this repository.

We evaluated the performance of the interoperable Cambridge hybrid closed-loop app with FreeStyle Libre 3 glucose sensor, and YpsoPump insulin pump in a real-world setting. Data from 100 users (63 adults [mean ± SD age 41.9 ± 14.0 years], 15 children [8.6 ± 5.2 years)] and 22 users of unreported age) for a period of 28 days were analyzed. Time in range (3.91- 10.0mmol/L) was 72.6 ± 11.1% overall. Time below range (<3.9mmol/L) was 3.1% (1.4-5.1) (median [interquartile range]). Auto-mode was active for 95.8% (91.8-97.9) of time. This real-world analysis suggests that the performance of Cambridge hybrid closed-loop app with this glucose sensor is comparable to other commercially available hybrid closed-loop systems.

Item Type:	Journal Article (Original Article)
Division/Institute:	04 Faculty of Medicine > Medical Education > Institute of General Practice and Primary Care (BIHAM)
UniBE Contributor:	Al-Alwan, Heba
Subjects:	600 Technology > 610 Medicine & health 300 Social sciences, sociology & anthropology > 360 Social problems & social services
ISSN:	1932-2968
Publisher:	Diabetes Technology Society
Language:	English
Submitter:	Pubmed Import
Date Deposited:	03 Aug 2023 14:00
Last Modified:	04 Aug 2023 19:23
Publisher DOI:	10.1177/19322968231187915
PubMed ID:	37503893
Uncontrolled Keywords:	CamAPS FX automated insulin delivery hybrid closed loop real world evidence
URI:	https://boris.unibe.ch/id/eprint/185116